Atlas Trials

An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A

Clinical trial NCT02577185 · COMPLETED

Trial details

NCT number
NCT02577185
Sponsor
LEO Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Psoriasis Vulgaris
Start date
2015-11-01
Primary completion
2016-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.